Lucas Rodriguez

Lucas Rodriguez has a diverse work experience spanning various industries and roles. Lucas started their career as a Candidate for Biomedical Engineering Master's at the University of Texas at Dallas, where they researched and developed novel two-solution bone cements. Lucas then continued their studies and worked as a Graduate Research Assistant, Graduate Laboratory & Project Manager, and Graduate Teaching Assistant at the same university.

In 2015, Lucas co-founded CerSci Therapeutics Inc, a biotechnology firm focused on non-opioid pharmaceutical treatment options for pain relief. Lucas served as the Chief Executive Officer and successfully completed Phase I Safety and Tolerability Studies for the company's lead clinical candidate.

Lucas later joined the University of Texas at Dallas as a Senior Lecturer and continued their academic pursuits. In addition to teaching, their role involved advanced research in the field of biomaterials, computer-aided design, finite element analysis, and medical device design.

In 2022, Lucas worked as a Consultant at Alacrita Consulting, gaining experience in providing expert advice and strategic guidance to clients in the healthcare industry.

Most recently, Lucas was appointed as the Chief Business Officer at Doloromics, where they are responsible for overseeing and managing the company's business operations.

Overall, Lucas Rodriguez has demonstrated a strong combination of academic excellence, entrepreneurial spirit, and industry expertise throughout their career.

Lucas Rodriguez completed their Bachelor of Science degree in Biology with a minor in Chemistry at Baylor University from 2006 to 2010. Lucas then pursued their Master's Degree in Bioengineering and Biomedical Engineering at The University of Texas at Dallas from 2012 to 2014. After completing their Master's, Lucas continued their education at The University of Texas at Dallas, earning a Doctor of Philosophy (Ph.D.) degree in Biomedical Engineering from 2012 to 2016.